{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:17:34Z","timestamp":1789964254325,"version":"4.0.1"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Health Research Bristol Cardiovascular Biomedical Research Unit"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jcrc.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T03:58:39Z","timestamp":1471233519000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials"],"prefix":"10.1016","volume":"37","author":[{"given":"Alessandro","family":"Belletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Biondi-Zoccai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Leggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Silvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni D.","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zangrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2016.08.010_bb0005","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2213-2600(14)70061-X","article-title":"Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit","volume":"2","author":"Vincent","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0010","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(10)60446-1","article-title":"Critical care and the global burden of critical illness in adults","volume":"376","author":"Adhikari","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0015","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.2014.2637","article-title":"Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012","volume":"311","author":"Kaukonen","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0020","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/CCM.0b013e318232db65","article-title":"Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007","volume":"40","author":"Lagu","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000000026","article-title":"Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis","volume":"42","author":"Stevenson","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0035","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0040","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0050","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7990","article-title":"Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study","volume":"13","author":"Morelli","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0055","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/cc7121","article-title":"Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial","volume":"12","author":"Morelli","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1074248414559838","article-title":"Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit","volume":"20","author":"Jentzer","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0065","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jcrc.2014.03.028","article-title":"Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment","volume":"29","author":"Antonucci","year":"2014","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-2-13","article-title":"The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C?","volume":"2","author":"Baker","year":"2002","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0080","first-page":"133","article-title":"The attractiveness of network meta-analysis: a comprehensive systematic and narrative review","volume":"7","author":"Greco","year":"2015","journal-title":"Heart Lung Vessel"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0085","first-page":"161","article-title":"The rough guide to systematic reviews and meta-analyses","volume":"3","author":"Biondi-Zoccai","year":"2011","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0090","first-page":"219","article-title":"Meta-analysis: pitfalls and hints","volume":"5","author":"Greco","year":"2013","journal-title":"Heart Lung Vessel"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0095","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ije\/dyh311","article-title":"A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials","volume":"34","author":"Biondi-Zoccai","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0110","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0115","series-title":"Network meta-analysis: evidence synthesis with mixed treatment comparison","year":"2014"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2288-13-35","article-title":"A graphical tool for locating inconsistency in network meta-analyses","volume":"13","author":"Krahn","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0125","author":"The R Core Team"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0130","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","article-title":"Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study","volume":"33","author":"Alban\u00e8se","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0135","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0140","first-page":"692","article-title":"Effects of levosimendan on hemodynamics and cardiac function in patients with septic shock","volume":"26","author":"Fang","year":"2014","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0145","first-page":"660","article-title":"Acute effect of dobutamine and amrinone on hemodynamics and splanchnic perfusion in septic shock patients","volume":"127","author":"Hern\u00e1ndez","year":"1999","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0150","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jemermed.2012.02.073","article-title":"Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock","volume":"44","author":"Hua","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0972-5229.63033","article-title":"Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock","volume":"14","author":"Jain","year":"2010","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0160","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/00003246-200108000-00004","article-title":"Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients","volume":"29","author":"Kern","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0165","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0170","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","article-title":"Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial","volume":"32","author":"Lauzier","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s001340050329","article-title":"Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study","volume":"23","author":"Levy","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0180","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/cc4845","article-title":"Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome","volume":"10","author":"Luckner","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0972-5229.99110","article-title":"Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock","volume":"16","author":"Mahmoud","year":"2012","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0190","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","article-title":"Low-dose vasopressin in the treatment of vasodilatory septic shock","volume":"47","author":"Malay","year":"1999","journal-title":"J Trauma"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0195","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jama.1994.03520170064037","article-title":"The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis","volume":"272","author":"Marik","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0200","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1378\/chest.103.6.1826","article-title":"Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?","volume":"103","author":"Martin","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0205","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0972-5229.37713","article-title":"Comparison of norepinephrine and dopamine in the management of septic shock using impedance cardiography","volume":"11","author":"Mathur","year":"2007","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0210","doi-asserted-by":"crossref","first-page":"318.e1","DOI":"10.1016\/j.jcrc.2011.06.008","article-title":"The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shock","volume":"27","author":"Memi\u015f","year":"2012","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0215","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0310057X0203000606","article-title":"The influence of methylene blue infusion on cytokine levels during severe sepsis","volume":"30","author":"Memi\u015f","year":"2002","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0220","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00134-005-2619-z","article-title":"Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression","volume":"31","author":"Morelli","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0225","doi-asserted-by":"crossref","first-page":"R232","DOI":"10.1186\/cc9387","article-title":"Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study","volume":"14","author":"Morelli","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0230","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bja\/aen017","article-title":"Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study","volume":"100","author":"Morelli","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0235","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/SHK.0b013e3181c6ba6f","article-title":"Efficacy and safety of dopamine versus norepinephrine in the management of septic shock","volume":"33","author":"Patel","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0240","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/00003246-199309000-00011","article-title":"Regional blood flow and oxygen transport in septic shock","volume":"21","author":"Ruokonen","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.jvca.2005.10.016","article-title":"Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock","volume":"20","author":"Schmoelz","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0250","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1067\/mcp.2002.122471","article-title":"Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock","volume":"71","author":"Seguin","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0255","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/cc4827","article-title":"Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212]","volume":"10","author":"Seguin","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0260","first-page":"1043","article-title":"Terlipressin in the treatment of late phase catecholamine-resistant septic shock","volume":"59","author":"Svoboda","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0265","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.biochi.2014.03.006","article-title":"Effects of levosimendan on mitochondrial function in patients with septic shock: a randomized trial","volume":"102","author":"Torraco","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0270","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock","volume":"370","author":"Yealy","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0275","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock","volume":"371","author":"Peake","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0280","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0285","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/cc13842","article-title":"Ventriculoarterial decoupling in human septic shock","volume":"18","author":"Guarracino","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0290","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2110-5820-1-27","article-title":"Microcirculatory alterations: potential mechanisms and implications for therapy","volume":"1","author":"De Backer","year":"2011","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0300","first-page":"274","article-title":"Isoproterenol infusion and microcirculation in septic shock","volume":"6","author":"Wiramus","year":"2014","journal-title":"Heart Lung Vessel"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0305","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13054-015-0794-z","article-title":"Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature","volume":"19","author":"Leone","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0310","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/aas.12581","article-title":"Microcirculatory dysfunction and tissue oxygenation in critical illness","volume":"59","author":"\u00d8stergaard","year":"2015","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0315","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.CCM.0000198107.61493.5A","article-title":"The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects","volume":"34","author":"De Backer","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0320","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00134-013-2982-0","article-title":"Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study","volume":"39","author":"Hernandez","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0325","doi-asserted-by":"crossref","first-page":"e103978","DOI":"10.1371\/journal.pone.0103978","article-title":"Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock","volume":"9","author":"den Uil","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0330","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/cc7922","article-title":"Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study","volume":"13","author":"Dubin","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0335","doi-asserted-by":"crossref","first-page":"e71659","DOI":"10.1371\/journal.pone.0071659","article-title":"The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis","volume":"8","author":"Pirracchio","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0340","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","article-title":"Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan","volume":"159","author":"Papp","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0345","first-page":"227","article-title":"Levosimendan: current data, clinical use and future development","volume":"5","author":"Nieminen","year":"2013","journal-title":"Heart Lung Vessel"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0350","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress","volume":"24","author":"D\u00fcnser","year":"2009","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0355","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13054-015-0803-2","article-title":"\u03b2-Blockers in critically ill patients: from physiology to clinical evidence","volume":"19","author":"Coppola","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0360","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2007.05.018","article-title":"Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty","volume":"128","author":"Dominguez-Rodriguez","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0365","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1399-6576.2007.01428.x","article-title":"Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy","volume":"51","author":"Guarracino","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0370","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jcrc.2015.05.017","article-title":"Levosimendan reduces mortality in patients with severe sepsis and septic shock: a meta-analysis of randomized trials","volume":"30","author":"Zangrillo","year":"2015","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0375","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bja\/aev284","article-title":"The effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials","volume":"115","author":"Belletti","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0380","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1745-6215-15-199","article-title":"An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial","volume":"15","author":"Orme","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0385","doi-asserted-by":"crossref","first-page":"e005866","DOI":"10.1136\/bmjopen-2014-005866","article-title":"Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH)","volume":"4","author":"Gordon","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0390","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/cc11469","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials","volume":"16","author":"Serpa Neto","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0395","doi-asserted-by":"crossref","first-page":"e0142605","DOI":"10.1371\/journal.pone.0142605","article-title":"Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials","volume":"10","author":"Belletti","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0400","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","article-title":"Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock","volume":"37","author":"Russell","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0405","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0410","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13054-015-1011-9","article-title":"Early goal-directed resuscitation of patients with septic shock: current evidence and future directions","volume":"19","author":"Gupta","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0415","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/CCM.0b013e31828a25fd","article-title":"Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense","volume":"41","author":"Marik","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0420","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13613-014-0021-0","article-title":"Iatrogenic salt water drowning and the hazards of a high central venous pressure","volume":"4","author":"Marik","year":"2014","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0425","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10877-012-9383-8","article-title":"Monitoring the microcirculation","volume":"26","author":"De Backer","year":"2012","journal-title":"J Clin Monit Comput"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0430","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcrc.2014.04.011","article-title":"Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials","volume":"29","author":"Oba","year":"2014","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0435","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2147\/TCRM.S80060","article-title":"Vasopressors in septic shock: a systematic review and network meta-analysis","volume":"11","author":"Zhou","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0440","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1378\/chest.11-2604","article-title":"The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock","volume":"142","author":"Gordon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0445","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0450","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0885066610396312","article-title":"Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials","volume":"27","author":"Vasu","year":"2012","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0455","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0b013e31823778ee","article-title":"Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis","volume":"40","author":"De Backer","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0460","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1097\/CCM.0b013e3181bc7bd5","article-title":"Why we should be wary of single-center trials","volume":"37","author":"Bellomo","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0465","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/CCM.0000000000000974","article-title":"Mortality in multicenter critical care trials: an analysis of interventions with a significant effect","volume":"43","author":"Landoni","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0470","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/CCM.0000000000000520","article-title":"Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study","volume":"42","author":"Waechter","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0475","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/SHK.0000000000000345","article-title":"Hemodynamic management of septic shock: is it time for \"individualized goal-directed hemodynamic therapy\" and for specifically targeting the microcirculation?","volume":"43","author":"Saugel","year":"2015","journal-title":"Shock"},{"key":"10.1016\/j.jcrc.2016.08.010_bb0480","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/EJA.0000000000000118","volume":"32","author":"Jammer","year":"2015","journal-title":"Eur J Anaesthesiol"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944116303422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944116303422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T08:58:42Z","timestamp":1556355522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944116303422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":96,"alternative-id":["S0883944116303422"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2016.08.010","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}